尿路CT成像再回顾
该综述回顾了腹部CT在尿路疾病中的临床应用,指出非增强CT是评估肾绞痛的标准方法,CT尿路造影(CTU)推荐用于血尿检查,CT在肾肿瘤和尿路上皮癌的诊断与分期中具有重要价值,但对膀胱癌肌层浸润的判断准确性有限。
要点
- 非增强CT是评估肾绞痛和检测泌尿系结石的标准影像方法。
- CTU推荐用于肉眼血尿及有泌尿系恶性肿瘤危险因素的镜下血尿检查。
- CT判断膀胱癌肌层浸润的准确性有限,需注意鉴别非肌层浸润性与肌层浸润性膀胱癌。
核心结论
- 腹部CT因普及性高、扫描快速及薄层各向同性数据支持多平面和三维重建,通常适合作为多种尿路疾病的首选影像检查。
- 非增强CT仍是评估肾绞痛的标准影像方法,可检测几乎所有类型的泌尿系结石并估算结石负荷。
- CT是表征不确定肾肿块(包括囊性和实性肿瘤)的主要诊断工具,也是原发性肾肿瘤分期的首选方式。
- CTU提高上、下尿路可视化,推荐用于肉眼血尿及有泌尿系恶性肿瘤易感因素的镜下血尿检查,对上尿路尿路上皮恶性肿瘤的检测和分期高度准确。
- CT是膀胱癌检测和分期最常用的技术,分期诊断效能随疾病进展而提高,但区分非肌层浸润性与肌层浸润性膀胱癌的准确性有限。
研究设计与样本
- 综述性论文,回顾尿路CT的临床适应证和最佳成像技术,并讨论常见泌尿系疾病(输尿管结石、肾肿瘤和尿路上皮癌)的CT特征。
关键影像表现/征象
- 非增强CT可检测几乎所有类型的泌尿系结石并估算结石负荷。
- CTU可提高上、下尿路可视化,用于血尿检查。
- CT可表征不确定肾肿块(囊性和实性肿瘤)并用于原发性肾肿瘤分期。
- CT用于膀胱癌检测和分期,分期诊断效能随疾病进展而提高。
诊断标准与关键数值
- 非增强CT为评估肾绞痛的标准影像方法。
- CTU推荐用于肉眼血尿及有泌尿系恶性肿瘤易感因素的镜下血尿检查。
临床应用与阅片要点
- 肾绞痛首选非增强CT,可检测结石并估算结石负荷。
- 不确定肾肿块(囊性或实性)应使用CT进行表征,原发性肾肿瘤分期也首选CT。
- 肉眼血尿及有泌尿系恶性肿瘤易感因素的镜下血尿推荐CTU检查。
- 膀胱癌检测和分期常用CT,但区分非肌层浸润性与肌层浸润性准确性有限,需注意。
局限性
- CT区分非肌层浸润性与肌层浸润性膀胱癌的准确性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Computed tomography (CT) of the abdomen is usually appropriate for the initial imaging of many urinary tract diseases, due to its wide availability, fast scanning and acquisition of thin slices and isotropic data, that allow the creation of multiplanar reformatted and three-dimensional reconstructed images of excellent anatomic details. Non-enhanced CT remains the standard imaging modality for assessing renal colic. The technique allows the detection of nearly all types of urinary calculi and the estimation of stone burden. CT is the primary diagnostic tool for the characterization of an indeterminate renal mass, including both cystic and solid tumors. It is also the modality of choice for staging a primary renal tumor. Urolithiasis and urinary tract malignancies represent the main urogenic causes of hematuria. CT urography (CTU) improves the visualization of both the upper and lower urinary tract and is recommended for the investigation of gross hematuria and microscopic hematuria, in patients with predisposing factors for urologic malignancies. CTU is highly accurate in the detection and staging of upper tract urothelial malignancies. CT represents the most commonly used technique for the detection and staging of bladder carcinoma and the diagnostic efficacy of CT staging improves with more advanced disease. Nevertheless, it has limited accuracy in differentiating non-muscle invasive bladder carcinoma from muscle-invasive bladder carcinoma. In this review, clinical indications and the optimal imaging technique for CT of the urinary tract is reviewed. The CT features of common urologic diseases, including ureterolithiasis, renal tumors and urothelial carcinomas are discussed.
引用
- Tsili, Varkarakis, Pasoglou, et al. CT of the urinary tract revisited. Eur J Radiol. 2023. PMID: 36773595. doi:10.1016/j.ejrad.2023.110717
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。